IL-33 administration increased the numbers of phagocytic microglial cells around APs, and the amounts of soluble Aβ were significantly reduced in the cortices of IL-33-treated APP/PS1 mice, preventing cognitive decline [2, 24, 80]. This evidence concerns the gene IL33 and Mental deterioration.